Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · MiniMed Group, Inc. (MMED)

MiniMed Q1 net sales rise 16.6% to $843 million; raises FY27 organic growth outlook

Positive Impact 4 of 5 earnings Written later

MiniMed reported first-quarter fiscal 2027 net sales of $843 million, up 16.6% from $723 million a year earlier, and reported net income of $0 compared with a loss of $16 million. The company raised its fiscal 2027 organic revenue growth guidance to approximately 10.5% from approximately 10%, while reaffirming its adjusted EBITDA margin guidance of approximately 16%.

Key points

  • Net sales were $843 million vs. $723 million; U.S. net sales grew 13.1% to $240 million and international grew 18.1% to $603 million.
  • Net income attributable to the company was $0 (EPS $0.00) vs. a loss of $19 million (EPS -$0.08) a year earlier.
  • FY27 organic revenue growth guidance raised to approximately 10.5% from approximately 10%; the figure includes a 1.0% to 1.5% benefit from an extra week in Q1.
  • Adjusted EBITDA margin guidance of approximately 16% was reaffirmed; a $2 million litigation benefit was recorded vs. a $17 million charge a year earlier.

The filing

CompanyMiniMed Group, Inc. (MMED)
Form8-K, current report
Filed with the SECSep 1, 2026, 6:50 AM ET
Accession number0001628280-26-059699

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:46 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 01, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.